Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer-Reference-Cited by-同舟云学术

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Published:2010-06-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Galaal Khadra¹,Naik Raj²,Bristow Robert E³,Patel Amit⁴,Bryant Andrew⁵,Dickinson Heather O⁵

Affiliation:

1. Princess Alexandra Wing, Royal Cornwall Hospital; Gynaecological Oncology; Truro UK TR1 3LJ

2. Northern Gynaecological Oncology Centre; Gynaecological Oncology; Queen Elizabeth Hospital Gateshead Tyne and Wear UK NE9 6SX

3. University of California - Irvine, Medical Center; Division of Gynecologic Oncology; Building 56, Room 260 101 The City Drive Orange CA USA 92868

4. University Hospitals Bristol NHS Foundation Trust; Gynaecological Oncology; St Michaels Hospital Southwell Street Bristol UK BS2 8EG

5. Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007822.pub2/fullpdf

Reference45 articles.

1. Harter P Kurzeder C du Bios A A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer ClinicalTrials.gov Identifier: NCT01166737 2012

2. The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery;Boente;Seminars in Oncology,1998

3. Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel;Bookman;Journal of Clinical Oncology,1998

4. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;Journal of Clinical Oncology,2002

5. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis;Bristow;Gynecologic Oncology,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia—A cross‐sectional study;International Journal of Gynecology & Obstetrics;2023-12-26

2. HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer;ecancermedicalscience;2023-03-31

3. Erkrankungen der Adnexe;Facharztwissen Gynäkologie;2021

4. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?;Journal of Obstetrics and Gynaecology;2020-01-14

5. The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients;Journal of Gynecologic Oncology;2019